Latest Liquidity News

Alterity Therapeutics is poised to release topline data from its pivotal ATH434-201 Phase 2 trial in early-stage Multiple System Atrophy by February 2025, while managing a cash balance of A$4.54 million amid ongoing research expenses.

Clime Investment Management has reported a return to profitability in the December half, proposing an interim dividend and unveiling strategic initiatives to drive future growth.

Income Asset Management delivered steady revenue of $4.0 million in Q2 FY2025 alongside significant growth in funds under administration and client accounts, while retiring $10 million in debt to reduce interest costs.

Southern Cross Gold Ltd has officially become a wholly owned subsidiary of Southern Cross Gold Consolidated Ltd following a scheme of arrangement, with shareholders receiving new securities and the company set for ASX delisting.

Volt Resources Limited has successfully repaid a AU$500,000 loan to RiverFort Global Opportunities, underscoring its financial discipline amid ongoing graphite project developments.

Multistack International Limited reported a net cash outflow from operating activities of $72,916 for the December 2024 quarter but ended with robust cash reserves of $975,608. Despite ongoing negative cash flows, the company remains confident in sustaining operations through secured financing and strategic asset acquisitions.

AMCIL Limited posted a half-year profit of $3.6 million, down 12.6%, yet its portfolio outperformed the S&P/ASX 200 with an 8.7% return. The company declared a steady interim dividend amid cautious market conditions.

Galilee Energy reports a $1.9 million R&D tax refund and terminates its merger with Vintage Energy, while maintaining steady progress at its Glenaras Gas Project and a robust cash position of $4.38 million.

Conrad Asia Energy reports solid progress in Q4 2024 with finalized gas sales agreements and promising LNG studies, despite delayed final investment decisions due to regulatory approvals.

Barton Gold Holdings reported a $1.74 million net cash outflow from operations in Q4 2024, ending the quarter with $7.01 million in cash and equivalents. The company’s available financing facilities and cash runway suggest cautious optimism for sustaining exploration activities.

SomnoMed Limited reported a solid cash flow performance for Q4 2024, with operating activities generating a net inflow of $1.525 million and ending the quarter with $18.5 million in cash reserves.

BSA Limited reported a robust Q2 FY2025 with revenue up 10.7% and EBITDA surging 31.5%, underpinned by a key contract extension with nbn. The company has upgraded its full-year EBITDA guidance, signaling confidence in sustained profitability.